VYNE Therapeutics, Inc. (VYNE)
0.385
+0.01
(+2.18%)
USD |
NASDAQ |
Dec 10, 12:57
VYNE Therapeutics EPS Diluted (Quarterly): -0.1701 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 0.0696 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.426M |
| Revenue (Quarterly) | 0.169M |
| Total Expenses (Quarterly) | 7.595M |
| Enterprise Value | -20.16M |
| Gross Profit Margin (Quarterly) | 96.45% |
| Profit Margin (Quarterly) | -4.39K% |
| Earnings Yield | -204.9% |
| Normalized Earnings Yield | -204.86 |